pepmg_

Study summary · research use only

Mechano Growth Factor Accelerates ACL Repair and Improves Cell Mobility of Mechanically Injured Human ACL Fibroblasts by Targeting Rac1-PAK1/2 and RhoA-ROCK1 Pathways

Study · human · International journal of molecular sciences · 2022 · DOI 10.3390/ijms23084331 · PMID 35457148

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This study combined in vitro work on human anterior cruciate ligament (ACL) fibroblasts with a rabbit partial ACL transection (ACLT) model to examine effects of mechano growth factor (MGF) after mechanical injury. After injurious mechanical stretch, cell area, roundness, migration, and adhesion of ACL fibroblasts were reduced at 0 and 24 h. MGF treatment (10, 100 ng/mL) was associated with improved cell area, roundness, migration, and adhesion, along with changes in expression of mobility-related molecules (PAK1/2, Cdc42, Rac1, RhoA, ROCK1). In the rabbit ACLT model, ACL exhibited poor regenerative capacity after partial ACLT for 2 or 4 weeks, and ACL regeneration and mechanical loading capacity were reported to be enhanced by MGF after partial ACLT for four weeks.

Abstract

Exceeded mechanical stress leads to a sublethal injury to anterior cruciate ligament (ACL) fibroblasts, and it will hinder cell mobility and ACL regeneration, and even induce osteoarthritis. The mechano growth factor (MGF) could be responsible for mechanical stress and weakening its negative effects on cell physiological behaviors. In this study, effects of MGF on cell mobility and relevant molecules expression in injured ACL fibroblasts were detected. After an injurious mechanical stretch, the analysis carried out, at 0 and 24 h, respectively, showed that the cell area, roundness, migration, and adhesion of ACL fibroblasts were reduced. MGF (10, 100 ng/mL) treatment could improve cell area, roundness and promote cell migration and adhesion capacity compared with the injured group without MGF. Further study indicated that cell mobility-relevant molecules (PAK1/2, Cdc42, Rac1, RhoA, and ROCK1) expression in ACL fibroblasts was down-regulated at 0 or 24 h after injurious stretch (except Rac1 and RhoA at 0 h). Similarly, MGF improved cell mobility-relevant molecule expression, especially the ROCK1 expression level in ACL fibroblasts at 0 or 24 h after injurious stretch. Protein expression of ROCK1 in injured ACL fibroblasts was also reduced and could be recovered by MGF treatment. In a rabbit partial ACL transection (ACLT) model, ACL exhibited poor regenerative capacity in collagen and extracellular matrix (ECM) synthesis after partial ACLT for 2 or 4 weeks, and MGF remarkably accelerated ACL regeneration and restored its mechanical loading capacity after partial ACLT for four weeks. Our findings suggest that MGF weakens the effects of pathological stress on cell mobility of ACL fibroblasts and accelerates ACL repair, and might be applied as a future treatment approach to ACL rupture in the clinic.

Read the full study on PubMed ↗ Open-access full text ↗

pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.